Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota F Cignarella, C Cantoni, L Ghezzi, A Salter, Y Dorsett, L Chen, D Phillips, ... Cell metabolism 27 (6), 1222-1235. e6, 2018 | 426 | 2018 |
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status L Piccio, Y Deming, JL Del-Águila, L Ghezzi, DM Holtzman, AM Fagan, ... Acta neuropathologica 131, 925-933, 2016 | 311 | 2016 |
Performance and complications of lumbar puncture in memory clinics: results of the multicenter lumbar puncture feasibility study FH Duits, P Martinez‐Lage, C Paquet, S Engelborghs, A Lleo, L Hausner, ... Alzheimer's & Dementia 12 (2), 154-163, 2016 | 229 | 2016 |
Circulating miRNAs as potential biomarkers in Alzheimer's disease D Galimberti, C Villa, C Fenoglio, M Serpente, L Ghezzi, SMG Cioffi, ... Journal of Alzheimer's Disease 42 (4), 1261-1267, 2014 | 225 | 2014 |
Disease-modifying drugs in Alzheimer’s disease L Ghezzi, E Scarpini, D Galimberti Drug design, development and therapy, 1471-1479, 2013 | 136 | 2013 |
Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients EE Longbrake, MJ Ramsbottom, C Cantoni, L Ghezzi, AH Cross, L Piccio Multiple Sclerosis Journal 22 (8), 1061-1070, 2016 | 122 | 2016 |
Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis C Cantoni, F Cignarella, L Ghezzi, B Mikesell, B Bollman, ... Acta neuropathologica 133, 61-77, 2017 | 84 | 2017 |
Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations A Arighi, GG Fumagalli, F Jacini, C Fenoglio, L Ghezzi, AM Pietroboni, ... Journal of Alzheimer's Disease 31 (2), 447-452, 2012 | 81 | 2012 |
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease C Villa, E Ridolfi, C Fenoglio, L Ghezzi, R Vimercati, F Clerici, A Marcone, ... Journal of Alzheimer's Disease 35 (3), 487-494, 2013 | 77 | 2013 |
Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred AM Pietroboni, GG Fumagalli, L Ghezzi, C Fenoglio, F Cortini, M Serpente, ... Journal of Alzheimer's Disease 24 (2), 253-259, 2011 | 70 | 2011 |
Immunotherapy against amyloid pathology in Alzheimer's disease D Galimberti, L Ghezzi, E Scarpini Journal of the neurological sciences 333 (1-2), 50-54, 2013 | 69 | 2013 |
Alterations of host-gut microbiome interactions in multiple sclerosis C Cantoni, Q Lin, Y Dorsett, L Ghezzi, Z Liu, Y Pan, K Chen, Y Han, Z Li, ... EBioMedicine 76, 2022 | 64 | 2022 |
Inflammatory molecules in frontotemporal dementia: cerebrospinal fluid signature of progranulin mutation carriers D Galimberti, R Bonsi, C Fenoglio, M Serpente, SMG Cioffi, G Fumagalli, ... Brain, behavior, and immunity 49, 182-187, 2015 | 61 | 2015 |
Effects of dietary restriction on neuroinflammation in neurodegenerative diseases L Fontana, L Ghezzi, AH Cross, L Piccio Journal of Experimental Medicine 218 (2), e20190086, 2021 | 58 | 2021 |
Targeting the gut to treat multiple sclerosis L Ghezzi, C Cantoni, GV Pinget, Y Zhou, L Piccio The Journal of Clinical Investigation 131 (13), 2021 | 55 | 2021 |
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients AM Pietroboni, L Dell’Arti, M Caprioli, M Scarioni, T Carandini, A Arighi, ... Multiple Sclerosis Journal 25 (1), 31-38, 2019 | 49 | 2019 |
The impact of osteopontin gene variations on multiple sclerosis development and progression C Comi, G Cappellano, A Chiocchetti, E Orilieri, S Buttini, L Ghezzi, ... Journal of Immunology Research 2012, 2012 | 49 | 2012 |
CSF β-amyloid and white matter damage: a new perspective on Alzheimer’s disease AM Pietroboni, M Scarioni, T Carandini, P Basilico, M Cadioli, G Giulietti, ... Journal of Neurology, Neurosurgery & Psychiatry, 2017 | 47 | 2017 |
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales GG Fumagalli, P Basilico, A Arighi, M Bocchetta, KM Dick, DM Cash, ... Alzheimer's research & therapy 10, 1-9, 2018 | 42 | 2018 |
Alterations of the gut mycobiome in patients with MS S Shah, A Locca, Y Dorsett, C Cantoni, L Ghezzi, Q Lin, S Bokoliya, ... EBioMedicine 71, 2021 | 38 | 2021 |